BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in Smoking Cessation

    NEXT STORY
    Aptose to Present at 31st Annual Piper Jaffray Healthcare Conference
    PREV STORY
    European Medicines Agency Accepts for Review Marketing Authorization Application for Amarin’s Icosapent Ethyl (Vascepa®) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in REDUCE-IT® Study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cidara Therapeutics Provides Clinical Data Updates for its Lead Antifungal Rezafungin

    Additional data and analyses from STRIVE Phase 2 clinical trial confirm positive efficacy results in ...

    author_avatar
    NASDAQ Market News

    Bavarian Nordic Announces Positive Data from Ongoing Phase 2 Study Investigating a Universal RSV Vaccine

    Company to host conference call at 3 pm CEST (9 am EDT) today to ...

    author_avatar
    NASDAQ Market News

    Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline

    Dosed First Patient in Cohort 3 in the ADVANCE Phase 1/2 Trial of ADVM-043 ...

    author_avatar
    NASDAQ Market News